Gong Haibin, Li Yun, Zheng Cheng, Du Tian-Tian, Luo Bing-Quan, Pang Min
Department of Cardiology, Xuzhou Central Hospital, Xuzhou Cardiovascular Disease Institute, Xuzhou, Jiangsu 221009, P.R. China.
Exp Ther Med. 2017 Jun;13(6):3217-3222. doi: 10.3892/etm.2017.4412. Epub 2017 Apr 28.
The present study explored the modulatory potential of hydrochlorothiazide and triamterene on resistant hypertension patients. The mechanistic information for resistant hypertension was explored by studying the pressure-natriuresis curves between the salt sensitive population and non-salt sensitive population. A cohort of 23 patients with non-hypertension (NH) (13 males and 10 females; aged from 23 to 62 years), 26 patients with controlled hypertension (CH) (14 males and 12 females; aged from 19 to 72 years) and 23 patients with resistant hypertension (RH) (13 males and 10 females; aged from 19 to 76 years) were selected. The patients were divided into two main groups on the basis of salt sensitivity viz. salt sensitive (SS) and non-SS (NSS) groups. These two groups were further classified into four subgroups based on the diuretic drug used. Hydrochlorothiazide-treated subgroups were named as salt sensitive hydrochlorothiazide (SSHy) and non-SSHy (NSSHy) groups. Similarly, triamterene-treated subgroups were named as salt sensitive triamterene (SSTr) and non-SSTr (NSSTr) groups. Treatment continued for 2 weeks and the pressure-natriuresis curves were recorded. Additionally, the plasma aldosterone and renin activity was monitored by radioimmunoassay. The pressure-natriuresis curves of the SS group were shifted towards the right relative to NSS group. On the other hand, hydrochlorothiazide and triamterene treatments reversed the changes of pressure-natriuresis curves. Moreover, significant differences were observed among various important indices including plasma aldosterone, renin activity, office blood pressure as evaluated by the chronic salt load test and diuretic intervention tests. The study concludes that hydrochlorothiazide and triamterene hold good potential as an efficient modulator of resistive hypertension.
本研究探讨了氢氯噻嗪和氨苯蝶啶对顽固性高血压患者的调节潜力。通过研究盐敏感人群和非盐敏感人群之间的压力-利钠曲线,探索了顽固性高血压的机制信息。选取了23例非高血压(NH)患者(13例男性和10例女性;年龄23至62岁)、26例血压控制良好的高血压(CH)患者(14例男性和12例女性;年龄19至72岁)和23例顽固性高血压(RH)患者(13例男性和10例女性;年龄19至76岁)。患者根据盐敏感性分为两个主要组,即盐敏感(SS)组和非盐敏感(NSS)组。这两组又根据使用的利尿剂药物进一步分为四个亚组。氢氯噻嗪治疗的亚组命名为盐敏感氢氯噻嗪(SSHy)组和非SSHy(NSSHy)组。同样,氨苯蝶啶治疗的亚组命名为盐敏感氨苯蝶啶(SSTr)组和非SSTr(NSSTr)组。治疗持续2周并记录压力-利钠曲线。此外,通过放射免疫测定法监测血浆醛固酮和肾素活性。SS组的压力-利钠曲线相对于NSS组向右移动。另一方面,氢氯噻嗪和氨苯蝶啶治疗逆转了压力-利钠曲线的变化。此外,在包括血浆醛固酮、肾素活性、通过慢性盐负荷试验和利尿剂干预试验评估的诊室血压等各种重要指标之间观察到显著差异。该研究得出结论,氢氯噻嗪和氨苯蝶啶作为顽固性高血压的有效调节剂具有良好的潜力。